Time filter

Source Type

Petah Tikva, Israel

Ram R.,BMT Unit Institute of Hematology | Ram R.,Tel Aviv University | Herscovici C.,BMT Unit Institute of Hematology | Herscovici C.,Tel Aviv University | And 8 more authors.
Leukemia Research | Year: 2014

We hypothesized that in patients with early post allogeneic transplantation toxicities, the omission of the 3rd dose of methotrexate with concomitant starting of MMF would favorably affect complications. We found a higher incidence of grade 2-4 acute GVHD in patients given two doses methotrexate and MMF (n=31) compared to those given three courses of methotrexate (n=70) (p=004), while grade 3-4 was similar. Other transplantation outcomes, including overall regimen-related-toxicity, were comparable. We conclude that tailoring the GVHD prophylaxis regimen may decrease the early post transplantation complications, however this come at the extent of a higher incidence of non-severe acute GVHD. © 2014 Elsevier Ltd. Source

Discover hidden collaborations